Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Interventional × MAGEA3 protein, human × Clear all

Phase

Status

Completed 10 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 458 Cyclophosphamide 317 Carboplatin 316 Radiotherapy 314 Paclitaxel 291 Capecitabine 288 Oxaliplatin 281 Docetaxel 275 Gemcitabine 274 Fluorouracil 248 apatinib 225 Drug Therapy 203 Bevacizumab 197 camrelizumab 187 Etoposide 177 Irinotecan 159 Doxorubicin 153 Dexamethasone 136 Leucovorin 135 Cytarabine 129 sintilimab 117 Pemetrexed 117 anlotinib 114 toripalimab 110 pembrolizumab 110 S 1 (combination) 108 Rituximab 108 Vincristine 106 Neoadjuvant Therapy 106 fludarabine 99

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00153569 2010-05-26

Multiepitope Peptide Vaccination in Melanoma

Charite University, Berlin, Germany

Phase 2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡